No black box warning on record for Oseltamavir Phosphate

As of the latest FDA labeling reviewed, Oseltamavir Phosphate (OSELTAMAVIR PHOSPHATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Oseltamavir Phosphate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiforme: Discontinue oseltamivir phosphate capsules and initiate appropriate treatment if allergic-like reactions occur or are suspected. ( 5.1 ) • Neuropsychiatric events: Patients with influenza, including those receiving oseltamivir phosphate capsules

No black box warning on record for Oseltamavir Phosphate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiforme: Discontinue oseltamivir phosphate capsules and initiate appropriate treatment if allergic-like reactions occur or are suspected. ( 5.1 ) • Neuropsychiatric events: Patients with influenza, including those receiving oseltamivir phosphate capsules

Oseltamavir Phosphate Black Box Warning

No black box warning on record for Oseltamavir Phosphate

Other warnings & precautions

Oseltamavir Phosphate Black Box Warning

No black box warning on record for Oseltamavir Phosphate

Other warnings & precautions